Jordheim LP - Search Results

1

Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction.

Barakat KH, Jordheim LP, Perez-Pineiro R, Wishart D, Dumontet C, Tuszynski JA. Barakat KH, et al. Among authors: jordheim lp. PLoS One. 2012;7(12):e51329. doi: 10.1371/journal.pone.0051329. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23272099 Free PMC article.

2

Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.

Bjånes TK, Jordheim LP, Schjøtt J, Kamceva T, Cros-Perrial E, Langer A, Ruiz de Garibay G, Kotopoulis S, McCormack E, Riedel B. Bjånes TK, et al. Among authors: jordheim lp. Drug Metab Dispos. 2020 Mar;48(3):153-158. doi: 10.1124/dmd.119.089334. Epub 2019 Dec 23. Drug Metab Dispos. 2020. PMID: 31871136

3

Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach.

Barakat KH, Torin Huzil J, Luchko T, Jordheim L, Dumontet C, Tuszynski J. Barakat KH, et al. J Mol Graph Model. 2009 Sep;28(2):113-30. doi: 10.1016/j.jmgm.2009.04.009. Epub 2009 May 4. J Mol Graph Model. 2009. PMID: 19473860

4

Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.

Jordheim LP, Marton Z, Rhimi M, Cros-Perrial E, Lionne C, Peyrottes S, Dumontet C, Aghajari N, Chaloin L. Jordheim LP, et al. Biochem Pharmacol. 2013 Feb 15;85(4):497-506. doi: 10.1016/j.bcp.2012.11.024. Epub 2012 Dec 7. Biochem Pharmacol. 2013. PMID: 23220537

5

Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells.

Jordheim LP, Barakat KH, Heinrich-Balard L, Matera EL, Cros-Perrial E, Bouledrak K, El Sabeh R, Perez-Pineiro R, Wishart DS, Cohen R, Tuszynski J, Dumontet C. Jordheim LP, et al. Mol Pharmacol. 2013 Jul;84(1):12-24. doi: 10.1124/mol.112.082347. Epub 2013 Apr 11. Mol Pharmacol. 2013. PMID: 23580445

6

Targeting the Nucleotide Metabolism Proteins of the NUDIX Family and SAMHD1 in Cancer.

Forey P, Cros-Perrial E, Dumontet C, Jordheim LP. Forey P, et al. Among authors: jordheim lp. Curr Med Chem. 2021;28(21):4088-4116. doi: 10.2174/0929867328666201125120422. Curr Med Chem. 2021. PMID: 33238840 Review.

7

Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair.

Ciniero G, Elmenoufy AH, Gentile F, Weinfeld M, Deriu MA, West FG, Tuszynski JA, Dumontet C, Cros-Perrial E, Jordheim LP. Ciniero G, et al. Among authors: jordheim lp. Cancer Chemother Pharmacol. 2021 Feb;87(2):259-267. doi: 10.1007/s00280-020-04213-x. Epub 2021 Jan 5. Cancer Chemother Pharmacol. 2021. PMID: 33399940

8

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.

Jordheim LP, Cros-Perrial E, Matera EL, Bouledrak K, Dumontet C. Jordheim LP, et al. Clin Exp Pharmacol Physiol. 2014 Oct;41(10):817-24. doi: 10.1111/1440-1681.12282. Clin Exp Pharmacol Physiol. 2014. PMID: 25115435

9

Characterization of T-DM1-resistant breast cancer cells.

Sauveur J, Conilh L, Beaumel S, Chettab K, Jordheim LP, Matera EL, Dumontet C. Sauveur J, et al. Among authors: jordheim lp. Pharmacol Res Perspect. 2020 Aug;8(4):e00617. doi: 10.1002/prp2.617. Pharmacol Res Perspect. 2020. PMID: 32583565 Free PMC article.

10

Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction.

Spasevska I, Matera EL, Chettab K, Ville J, Potier-Cartereau M, Jordheim LP, Thieblemont C, Sahin D, Klein C, Dumontet C. Spasevska I, et al. Among authors: jordheim lp. Mol Cancer Ther. 2020 Nov;19(11):2371-2381. doi: 10.1158/1535-7163.MCT-19-0839. Epub 2020 Aug 26. Mol Cancer Ther. 2020. PMID: 32847969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results